Unilateral intranigral administration of baclofen (50–200 ng), muscimol (2.5–20 ng), or THIP (50–400 ng) in the rat led to contralateral circling behavior of a qualitatively similar nature. The potency of all three GABA-mimetics was enhanced in animals which had received the depot neuroleptic fluphenazine decanoate (10 mg/kg SC) 7 days prior to their intranigral administration. Significant differences between the nigral actions of the drugs could be demonstrated by their altered activity in the presence of a benzodiazepine. Flurazepam (500 ng) enhanced the intranigral potency of THIP, but reduced that of intranigral baclofen. Muscimol-induced circling behavior was unaffected by concomitant flurazepam. The data provide evidence for a functional supersensitivity of GABA-sensitive nondopaminergic projections from the substantia nigra in response to chronic neuroleptic treatment and reveal differences between the precise sites or modes of action of baclofen, muscimol, and THIP within this structure.
This is a preview of subscription content, log in via an institution to check access.
Access this article Subscribe and saveSpringer+ Basic
€34.99 /Month
Price includes VAT (Germany)
Instant access to the full article PDF.
Similar content being viewed by others Explore related subjectsDiscover the latest articles and news from researchers in related subjects, suggested using machine learning. ReferencesAllan RD, Evans RH, Johnston GAR (1980) γ-Aminobutyric acid agonists: An in vitro comparison between depression of spinal synaptic activity and depolarization of spinal root fibres in the rat. Br J Pharmacol 70:609–615
Andén NE, Stock G (1973) Inhibitory effect of gammahydroxybutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedebergs Arch Pharmacol 279:89–92
Arnt J, Scheel-Krüger J (1979) GABAergic and glycinergic mechanisms within the substantia nigra: Pharmacological specificity of dopamine-independent contralateral turning behaviour and interactions with other neurotransmitters. Psychopharmacology 62:267–277
Braestrup C, Nielsen M, Krogsgaard-Larsen P, Falch E (1979) Partial agonists for brain GABA/benzodiazepine receptor complex. Nature 280:331–333
Clavier RM, Admadja S, Fibiger HC (1976) Nigrothalamic projections in the rat as demonstrated by orthograde and retrograde tracing techniques. Brain Res Bull 1:379–384
Enna SJ (1981) GABA receptors. Trends Pharmacol Sci 2:62–64
Enna SJ, Bennett JP, Bylund DB, Snyder SH, Bird ED, Iversen LL (1976) Alterations of brain neurotransmitters binding in Huntington's chorea. Brain Res 116:531–537
Gale K (1980) Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra. Nature 287:569–570
Gale K, Costa E, Toffano G, Hong JS, Guidotti A (1978) Evidence for a role of nigral γ-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase. J Pharmacol Exp Ther 206:29–37
Graybiel AM (1978) Organisation of the nigro-tectal connection in an experimental tracer study in the cat. Brain Res 143:125–138
Hill DR, Bowery NG (1981) 3H-Baclofen and 3H-GABA bind to bicuculline-insensitive GABA-B sites in rat brain. Nature 290:149–152
James RA, Starr MS (1978) The role of GABA in the substantia nigra. Nature 275:229–230
König JFR, Klippel RA (1963) The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams and Wilkins, Baltimore
Kozlowski MR, Marshall JF (1980) Rotations induced by intra-nigral injections of GABA agonists and antagonists: Zone-specific effects. Pharmacol Biochem Behav 13:561–567
Lloyd KG, Shemen L, Hornykiewicz O (1977) Distribution of high affinity sodium-independent 3H-gamma-aminobutyric acid (3H-GABA) binding in the human brain: Alterations in Parkinson's disease. Brain Res 127:269–278
Marco E, Mao CC, Revueleta A, Peralta E, Costa E (1978) Turnover rates of γ-aminobutyric acid in substantia nigra, N. caudatus, globus pallidus and N. accumbens of rats injected with cataleptogenic and non-cataleptogenic antipsychotics. Neuropharmacology 17:589–596
Morelli M, Porceddu ML, Di Chiara G (1980) Lesions of substantia nigra by kainic acid: Effects on apomorphine-induced behaviour. Brain Res 191:67–78
Olianas MC, De Montis GM, Mulas G, Tagliamonte A (1978) The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway. Eur J Pharmacol 49:233–241
Papadopoulos G, Huston JP (1980) Removal of the telencephalon spares turning induced by injection of GABA agonists and antagonists into the substantia nigra. Behav Brain Res 1:25–38
Pope SG, Dean P, Redgrave P (1980) Dissociation of d-amphetamine-induced locomotor activity and stereotyped behaviour by lesions of the superior colliculus. Psychopharmacology 70:297–302
Racagni G, Bruno F, Cattabeni F, Maggi A, Di Giulio AM, Parenti M, Groppetti A (1977) Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation. Brain Res 134:353–358
Rinvik E, Grovofa I, Ottersen PO (1976) Demonstration of nigro-tectal and nigro-reticular projections in the cat by axonal transport of proteins. Brain Res 112:388–394
Scheel-Krüger J, Arnt J, Magelund G (1977) Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. Neurosci Lett 4:351–356
Waddington JL, Cross AJ (1978) Denervation supersensitivity in the striatonigral pathway. Nature 276:618–620
Waddington JL, Cross AJ (1979) Baclofen and muscimol: Behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding. Naunyn Schmiedebergs Arch Pharmacol 306:275–280
Wheeler SC, Roth RH (1980) Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. Naunyn Schmiedebergs Arch Pharmacol 312:151–159
Wander Research Institute (a Sandoz Research Unit), Wander Ltd., PO Box 2747, CH-3001, Berne, Switzerland
D. M. Coward
Coward, D.M. Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam. Psychopharmacology 76, 294–298 (1982). https://doi.org/10.1007/BF00432565
Received: 29 September 1981
Accepted: 07 January 1982
Issue Date: March 1982
DOI: https://doi.org/10.1007/BF00432565
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4